+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neuralgia Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Delivery Mode (Injectable, Oral, Topical), End User, Distribution Channel, Indication, Drug Class - Global Forecast 2025-2030- Product Image
Neuralgia Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Delivery Mode (Injectable, Oral, Topical), End User, Distribution Channel, Indication, Drug Class - Global Forecast 2025-2030- Product Image
Sale

Neuralgia Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Delivery Mode (Injectable, Oral, Topical), End User, Distribution Channel, Indication, Drug Class - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146088
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neuralgia treatment market is evolving rapidly, driven by technological innovation, shifting patient demographics, and increased demand for precision-based therapies. As advances reshape clinical pathways, industry stakeholders seek actionable insight to respond effectively and enhance patient outcomes in a competitive therapeutic landscape.

Market Snapshot: Neuralgia Treatment Market Size & Growth

The Neuralgia Treatment Market grew from USD 1.20 billion in 2024 to USD 1.35 billion in 2025. It is expected to continue growing at a CAGR of 12.45%, reaching USD 2.42 billion by 2030. This expansion underscores increasing prioritization of effective pain management across healthcare systems, supported by a pipeline of advanced neuromodulation technologies and evolving pharmacological solutions. High prevalence of neuropathic disorders and the need for targeted therapies position the neuralgia management market for sustained momentum.

Scope & Segmentation

This research report provides an in-depth analysis of the neuralgia treatment landscape by covering the following:

  • Treatment Types: Non pharmacological interventions such as acupuncture, neuromodulation, physical therapy, and pharmacological approaches.
  • Delivery Modes: Injectable, oral, topical, and transdermal options tailored to patient needs and clinical scenarios.
  • End Users: Ambulatory surgical centers, home healthcare providers, hospitals, and specialty clinics addressing various levels of care requirement.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy distributing therapies and devices to diverse patient populations.
  • Indications: Chemotherapy-induced neuralgia, diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia as primary clinical drivers for product development.
  • Drug Classes: Anticonvulsants, antidepressants, local anesthetics, NSAIDs, opioids, and topical agents comprising the therapy spectrum.
  • Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, with further detail on leading countries and regional healthcare dynamics.
  • Company Landscape: Major market players including Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi S.A., Johnson & Johnson, GlaxoSmithKline plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Grünenthal GmbH, and Viatris Inc.

Key Takeaways

  • Ongoing R&D prioritizes patient-tailored interventions, leveraging cross-disciplinary collaboration to develop multimodal neuralgia therapies that integrate digital health and device-based platforms.
  • Advances in neuromodulation, such as closed-loop spinal cord stimulators, are redefining standards of care by enabling adaptive, real-time pain management for complex neuralgia cases.
  • Integration of telemedicine and remote monitoring strengthens therapy persistence and optimizes decision-making based on real-world evidence, benefiting both patients and providers.
  • Strategic partnerships between pharmaceutical, biotechnology, and medtech companies accelerate innovation, combination therapies, and global market penetration, while emerging biotech investments signal robust confidence in next-generation modalities.
  • Regional markets demonstrate unique growth drivers, with mature regions emphasizing value-based care and innovation, while developing markets focus on accessibility and regulatory support for affordable treatment solutions.

Tariff Impact: Navigating Cost Pressures & Supply Chain Shifts

The 2025 U.S. tariff adjustments on medical devices and pharmaceutical components have intensified cost pressures across the neuralgia supply chain. Device manufacturers are reevaluating sourcing strategies by exploring onshore and nearshore production to manage lead times and supplier risk. Pharmaceutical firms are leveraging supply agreements and bonded warehousing to offset elevated import duties on key ingredients. These responses highlight the importance of supply chain resilience and localized manufacturing in maintaining pricing stability and market access for essential neuralgia treatments.

Methodology & Data Sources

This report employs rigorous secondary research, cross-verified with primary interviews from leading clinicians, executives, and key opinion leaders. Data triangulation, site visits, and statistical validation ensure comprehensive trend analysis and reliable scenario assessments across market segments.

Why This Report Matters

  • Provides actionable segmentation and industry benchmarking for senior decision-makers seeking competitive advantage in neuralgia care innovation.
  • Guides strategic alignment with evolving regulatory policies, technology trends, and regional growth drivers for more precise business planning.
  • Empowers organizations to anticipate supply chain disruptions, optimize partnerships, and drive patient-centric therapies in complex market conditions.

Conclusion

The neuralgia treatment market is dynamic, shaped by innovation, collaborative strategies, and proactive supply chain responses. Senior leaders gain a clear pathway to drive value, boost patient outcomes, and strengthen their market position in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding use of gene therapy approaches for hereditary and idiopathic neuralgia treatment
5.2. Integration of neuromodulation devices with closed loop feedback systems for personalized pain relief
5.3. Emergence of targeted monoclonal antibody therapies for refractory neuropathic pain management
5.4. Adoption of AI driven predictive analytics platforms to optimize neuralgia treatment regimens
5.5. Advancements in minimally invasive percutaneous nerve ablation techniques for chronic neuralgia
5.6. Development of combination pharmacotherapy and neurostimulation protocols for enhanced analgesia
5.7. Growing pipeline of regenerative stem cell interventions for peripheral nerve repair in neuralgia patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neuralgia Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non Pharmacological
8.2.1. Acupuncture
8.2.2. Neuromodulation
8.2.3. Physical Therapy
8.3. Pharmacological
9. Neuralgia Treatment Market, by Delivery Mode
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
9.5. Transdermal
10. Neuralgia Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Healthcare
10.4. Hospitals
10.5. Specialty Clinics
11. Neuralgia Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Neuralgia Treatment Market, by Indication
12.1. Introduction
12.2. Chemotherapy Induced Neuralgia
12.3. Diabetic Neuropathy
12.4. Postherpetic Neuralgia
12.5. Trigeminal Neuralgia
13. Neuralgia Treatment Market, by Drug Class
13.1. Introduction
13.2. Anticonvulsants
13.3. Antidepressants
13.4. Local Anesthetics
13.5. NSAIDs
13.6. Opioids
13.7. Topical Agents
14. Americas Neuralgia Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Neuralgia Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Neuralgia Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Eli Lilly and Company
17.3.3. Novartis AG
17.3.4. Sanofi S.A.
17.3.5. Johnson & Johnson
17.3.6. GlaxoSmithKline plc
17.3.7. AbbVie Inc.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Grünenthal GmbH
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NEURALGIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NEURALGIA TREATMENT MARKET: RESEARCHAI
FIGURE 28. NEURALGIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. NEURALGIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. NEURALGIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEURALGIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NEUROMODULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY CHEMOTHERAPY INDUCED NEURALGIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY CHEMOTHERAPY INDUCED NEURALGIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 110. CANADA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 111. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 112. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 113. CANADA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 120. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 210. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 211. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ITALY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 238. ITALY NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 239. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 240. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 241. ITALY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ITALY NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 252. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 253. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 254. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 255. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 304. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 306. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 307. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 308. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 309. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 310. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 311. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 330. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 331. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 332. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 333. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 334. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 335. QATAR NEURALGIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 336. Q

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neuralgia Treatment market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Grünenthal GmbH
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.42 Billion
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Neuralgia Treatment Market Report 2025 - Product Image

Neuralgia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Post Herpetic Neuralgia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Post Herpetic Neuralgia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Neuralgia Drug Market

Neuralgia is a type of chronic pain that affects the nerves of the central nervous system. It is often caused by nerve damage or irritation, and can be difficult to treat. Neuralgia drugs are used to reduce the pain associated with this condition. These drugs work by blocking the transmission of pain signals from the affected nerves to the brain. Commonly used neuralgia drugs include anticonvulsants, antidepressants, and opioids. These drugs can be taken orally, injected, or applied topically. The neuralgia drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. These companies are constantly developing new drugs and treatments to improve the quality of life for those suffering from neuralgia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.